Haemolytic anaemia after oral artemether-lumefantrine treatment in a patient affected by severe imported falciparum malaria

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Artemisinin and its derivatives are essential components of artemisinin-based combination therapies for treating severe falciparum malaria. In this paper, we describe the occurrence of haemolysis after oral artemether-lumefantrine treatment. To the best of our knowledge, this is the second reported case of a patient affected by severe falciparum malaria with haemolytic anaemia that is likely associated with oral artemether-lumefantrine treatment.

Original languageEnglish
Pages (from-to)863-865
Number of pages3
JournalInfection
Volume41
Issue number4
DOIs
Publication statusPublished - Aug 2013

Fingerprint

Falciparum Malaria
Hemolytic Anemia
Hemolysis
Therapeutics
lumefantrine
artemether
artemisinine

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Cite this

@article{d45e513d87d2498a9a019813827a76a9,
title = "Haemolytic anaemia after oral artemether-lumefantrine treatment in a patient affected by severe imported falciparum malaria",
abstract = "Artemisinin and its derivatives are essential components of artemisinin-based combination therapies for treating severe falciparum malaria. In this paper, we describe the occurrence of haemolysis after oral artemether-lumefantrine treatment. To the best of our knowledge, this is the second reported case of a patient affected by severe falciparum malaria with haemolytic anaemia that is likely associated with oral artemether-lumefantrine treatment.",
author = "{De Nardo}, P. and A. Oliva and Giancola, {M. L.} and P. Ghirga and P. Mencarini and M. Bibas and E. Nicastri and A. Antinori and A. Corpolongo",
year = "2013",
month = "8",
doi = "10.1007/s15010-013-0451-x",
language = "English",
volume = "41",
pages = "863--865",
journal = "Infection",
issn = "0300-8126",
publisher = "Urban und Vogel GmbH",
number = "4",

}

TY - JOUR

T1 - Haemolytic anaemia after oral artemether-lumefantrine treatment in a patient affected by severe imported falciparum malaria

AU - De Nardo, P.

AU - Oliva, A.

AU - Giancola, M. L.

AU - Ghirga, P.

AU - Mencarini, P.

AU - Bibas, M.

AU - Nicastri, E.

AU - Antinori, A.

AU - Corpolongo, A.

PY - 2013/8

Y1 - 2013/8

N2 - Artemisinin and its derivatives are essential components of artemisinin-based combination therapies for treating severe falciparum malaria. In this paper, we describe the occurrence of haemolysis after oral artemether-lumefantrine treatment. To the best of our knowledge, this is the second reported case of a patient affected by severe falciparum malaria with haemolytic anaemia that is likely associated with oral artemether-lumefantrine treatment.

AB - Artemisinin and its derivatives are essential components of artemisinin-based combination therapies for treating severe falciparum malaria. In this paper, we describe the occurrence of haemolysis after oral artemether-lumefantrine treatment. To the best of our knowledge, this is the second reported case of a patient affected by severe falciparum malaria with haemolytic anaemia that is likely associated with oral artemether-lumefantrine treatment.

UR - http://www.scopus.com/inward/record.url?scp=84881088339&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84881088339&partnerID=8YFLogxK

U2 - 10.1007/s15010-013-0451-x

DO - 10.1007/s15010-013-0451-x

M3 - Article

C2 - 23553281

AN - SCOPUS:84881088339

VL - 41

SP - 863

EP - 865

JO - Infection

JF - Infection

SN - 0300-8126

IS - 4

ER -